(TVTX) – Analyst Ratings
-
Guggenheim Downgrades Travere Therapeutics (TVTX) to Neutral
-
Evercore ISI on Travere Therapeutics (TVTX): 'We think the stock remains undervalued'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TVTX Stock Lookup